Publications by authors named "Katy Wilkens"
Article Synopsis
- The KDIGO 2022 Clinical Practice Guideline updates the 2020 guidelines for managing diabetes in patients with chronic kidney disease (CKD), based on new evidence and a structured evaluation approach.
- Key changes were made to recommendations in areas related to comprehensive care and glucose-lowering therapies, while other chapters maintained their prior guidance.
- Clinicians are advised to focus on preserving kidney function through a layered care strategy that includes lifestyle changes, self-management, and specific medications that enhance heart and kidney protection, along with managing risk factors for CKD and cardiovascular issues.
The Kidney Disease: Improving Global Outcomes (KDIGO) 2022 Clinical Practice Guideline for Diabetes Management in Chronic Kidney Disease (CKD) represents a focused update of the KDIGO 2020 guideline on the topic. The guideline targets a broad audience of clinicians treating people with diabetes and CKD. Topic areas for which recommendations are updated based on new evidence include Chapter 1: Comprehensive care in patients with diabetes and CKD and Chapter 4: Glucose-lowering therapies in patients with type 2 diabetes (T2D) and CKD.
View Article and Find Full Text PDFDescription: The Kidney Disease: Improving Global Outcomes (KDIGO) organization developed a clinical practice guideline in 2020 for the management of patients with diabetes and chronic kidney disease (CKD).
Methods: The KDIGO Work Group (WG) was tasked with developing the guideline for diabetes management in CKD. It defined the scope of the guideline, gathered evidence, determined systematic review topics, and graded evidence that had been summarized by an evidence review team.
Article Synopsis
- The KDIGO Clinical Practice Guideline is the first guideline focused on managing diabetes in patients with chronic kidney disease (CKD), aiming to improve health outcomes amidst new treatment options.
- It emphasizes the use of recent advancements, particularly sodium-glucose cotransporter-2 inhibitors and glucagon-like peptide-1 receptor agonists, backed by high-quality evidence from clinical trials.
- The guideline provides evidence-based recommendations for comprehensive care, including glycemic monitoring, lifestyle changes, and a range of therapies, while also offering practical points for implementation when data is limited.
Heuristic evaluation is a type of study that is useful for uncovering usability issues in a human-computer interface such as the electronic medical record (EMR). Findings can be very useful in overcoming usability problems to better realize the benefits of the EMR. Correction of the usability violations will improve the efficiency and effectiveness of EMRs.
View Article and Find Full Text PDF